BioIntelligence Technologies, a firm that has created an AI-powered solution to minimise product losses, minimise energy and water use, and lower CO2 emissions in industrial bioprocesses that use fermentation secures $5million in funding.
Innospark Ventures, Investissement Québec, Real Ventures, Anges Québec, and AQC Capital also participated in the round, which was headed by Amplify Capital.
The business plans to utilise the money to expand more quickly in Europe and America. Under the direction of CEO and founder Joel Sirois, BioIntelligence designs, develops, and sells cutting-edge and intelligent hardware and software that helps biotech businesses track, comprehend, forecast, and improve bioprocess performance, which lowers product losses, boosts consistency, and boosts earnings for industrial customers.
Read also – TX-based Backflip Secures $15Million in Series A Round Funding – FUNDING NEWS
The BioIntelligence Analytics SolutionTM (BASTM) was created to evaluate the growth of microorganisms, how they use nutrients, and how they synthesise products directly in fermenters and bioreactors. It also provides plant operators with real-time, advanced, customised analytics.
About BioIntelligence Technologies Inc
Industrial bioprocesses are enhanced in real-time by BioIntelligence Technologies Inc. for increased productivity, repeatability, and profitability. Manufacturers of industrial biochemicals, biofuel, food additives, biofertilizers, alternative proteins, cosmetics, biologics, etc. are among BioIntelligence’s clientele. In actuality, any production that makes use of microbes in a tank.
They increase trust in product quality while maximising full-scale profitability and mitigating risk associated with bioprocess scale-ups by utilising the BioIntelligence Analytics SolutionTM.
